CLINICAL_TRIALS
trial_result
· 2011-06-03
Clinical Trial Update: Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis [Phase 3]
Summary
A Phase 3 substudy evaluation of a low-dose abatacept in rheumatoid arthritis has completed, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-06-03